bioMerieux launches two new culture media for MFTs

8 April 2009

French diagnostics firm bioMerieux has launched two culture media for Media Fill Tests: TSB 3P with Animal Peptones and TSB 3P with Vegetable  Peptones and a color indicator to enhance efficiency and reduce  potential errors.

Media Fill Tests are used for this microbiological control. They  simulate the normal manufacturing conditions by replacing the product  with culture media. Current practice requires the manual reading of  several thousand containers filled with this culture media for each MFT.  Since each container must be checked individually, this practice is  extremely time-consuming and can be a source of potential errors.

To address these issues, bioMerieux has pioneered two new dehydrated  culture media products designed for use in MFT. Both media are TSE-free  to prevent any risk of transmitting animal spongiform encephalopathy.  The TSB 3P with Vegetable Peptones features a unique and patented color  indicator that changes from pink to yellow if a bacterial contaminant is  present, which simplifies the interpretation of the test result and  reduces the possibility of errors.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight